Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer
Journal article published in 2021 by
Takafumi Yanagisawa 
,
Takahiro Kimura ,
Keiichiro Mori,
Hirotaka Suzuki,
Takayuki Sano,
Takashi Otsuka,
Yuya Iwamoto,
Wataru Fukuokaya ,
Keiichiro Miyajima,
Yuki Enei,
Keigo Sakanaka,
Akihiro Matsukawa,
Hajime Onuma,
Koki Obayashi,
Shunsuke Tsuzuki
and other authors.
,
Takahiro Kimura ,
Keiichiro Mori,
Hirotaka Suzuki,
Takayuki Sano,
Takashi Otsuka,
Yuya Iwamoto,
Wataru Fukuokaya ,
Keiichiro Miyajima,
Yuki Enei,
Keigo Sakanaka,
Akihiro Matsukawa,
Hajime Onuma,
Koki Obayashi,
Shunsuke Tsuzuki
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 